Beactica

Beactica Therapeutics AB is a specialist drug discovery and development company, committed to the fight against cancer. Beactica is advancing a proprietary pipeline of first-in-class therapeutics by applying its molecular interaction-based drug discovery engine synergistically across multiple small molecule modalities - including allosteric modulators, protein-protein interaction inhibitors and targeted protein degraders (PROTACs).